Metaplanet
3350
DeNA
2432
Nippon Telegraph & Telephone
9432
4
Mitsubishi Heavy Industries
7011
5
Takeda Pharmaceutical
4502
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 16.92%6.64B | 2.41%25.04B | 6.00%6.45B | -2.12%5.68B | 5.12%24.45B | 5.99B | 7.49%6.57B | 4.12%6.09B | 13.10%5.8B | 8.90%23.26B |
Cost of revenue | 9.63%4.58B | 1.35%17.85B | 6.22%4.61B | 0.55%4.17B | 7.10%17.61B | 4.43B | 8.84%4.69B | 6.53%4.34B | 14.42%4.15B | 6.82%16.44B |
Gross profit | 37.23%2.06B | 5.12%7.19B | 5.44%1.84B | -8.90%1.5B | 0.34%6.84B | 1.56B | 4.21%1.88B | -1.36%1.75B | 9.92%1.65B | 14.25%6.82B |
Operating expense | 5.13%553M | -1.59%2.23B | 0.35%570M | -12.91%526M | -14.05%2.26B | 510M | -17.24%581M | -16.84%568M | -3.97%604M | 2.05%2.63B |
Staff costs | ---- | 0.15%673M | ---- | ---- | -10.28%672M | ---- | ---- | ---- | ---- | 4.90%749M |
Selling and administrative expenses | ---- | -6.25%495M | ---- | ---- | -27.47%528M | ---- | ---- | ---- | ---- | 10.30%728M |
-Selling and marketing expense | ---- | -21.88%25M | ---- | ---- | -8.57%32M | ---- | ---- | ---- | ---- | -14.63%35M |
-General and administrative expense | ---- | -5.24%470M | ---- | ---- | -28.43%496M | ---- | ---- | ---- | ---- | 11.95%693M |
Research and development costs | ---- | -9.61%367M | ---- | ---- | -10.57%406M | ---- | ---- | ---- | ---- | -10.10%454M |
Depreciation and amortization | ---- | 8.94%134M | ---- | ---- | 4.24%123M | ---- | ---- | ---- | ---- | -10.61%118M |
-Depreciation | ---- | 8.94%134M | ---- | ---- | 4.24%123M | ---- | ---- | ---- | ---- | -10.61%118M |
Other operating expenses | ---- | 4.49%558M | ---- | ---- | -8.56%534M | ---- | ---- | ---- | ---- | 2.64%584M |
Operating profit | 54.50%1.51B | 8.44%4.96B | 7.89%1.27B | -6.59%978M | 9.40%4.58B | 1.05B | 17.83%1.3B | 8.36%1.18B | 19.93%1.05B | 23.54%4.18B |
Net non-operating interest income (expenses) | -15.91%74M | 2.92%423M | 5.74%129M | -3.30%88M | 31.31%411M | 103M | 1.06%95M | 56.41%122M | 51.67%91M | 26.21%313M |
Non-operating interest income | -15.91%74M | 2.92%423M | 5.74%129M | -3.30%88M | 31.31%411M | --103M | 1.06%95M | 56.41%122M | 51.67%91M | 26.21%313M |
Net investment income | -193.24%-138M | 77.29%367M | -14.29%216M | 1,445.45%148M | -37.84%207M | -118M | -61.64%84M | -6.67%252M | -112.09%-11M | 48.66%333M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 68M | 252.50%61M | -200.00%-1M | 0 | -101.37%-40M | -83M | -99.92%1M | -99.94%1M | -80.75%41M | 20,950.00%2.92B |
Less:Other special charges | ---68M | -252.50%-61M | ---- | ---- | 101.30%40M | --83M | 99.92%-1M | 99.95%-1M | 80.75%-41M | -22,064.29%-3.08B |
Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --156M |
Other non-operating income (expenses) | -9.09%20M | -23.33%92M | -8.33%22M | -52.17%22M | -0.83%120M | 28M | 4.76%22M | -52.94%24M | 84.00%46M | 42.35%121M |
Income before tax | 24.07%1.54B | 11.99%5.9B | 3.54%1.64B | 2.06%1.24B | -32.98%5.27B | 972M | -43.05%1.5B | -50.82%1.58B | -3.88%1.21B | 100.38%7.86B |
Income tax | 14.48%427M | 12.56%1.69B | -19.76%463M | 70.32%373M | -45.52%1.5B | 265M | -42.40%436M | -41.66%577M | -33.23%219M | 185.65%2.75B |
Net income | 28.36%1.11B | 11.80%4.22B | 16.93%1.17B | -13.08%864M | -26.26%3.77B | 706M | -43.28%1.07B | -54.92%1B | 6.54%994M | 72.69%5.12B |
Net income continuous operations | 28.21%1.11B | 11.77%4.22B | 16.93%1.17B | -12.98%865M | -26.24%3.77B | --707M | -43.31%1.07B | -54.90%1B | 6.42%994M | 72.69%5.12B |
Noncontrolling interests | 1,550.00%29M | -30.38%55M | -33.33%16M | -116.67%-2M | -14.13%79M | 21M | -64.52%22M | 1,300.00%24M | 50.00%12M | -36.55%92M |
Net income attributable to the company | 24.45%1.08B | 12.70%4.16B | 18.06%1.16B | -11.62%867M | -26.46%3.69B | 686M | -42.59%1.05B | -56.01%980M | 6.05%981M | 78.27%5.02B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 24.45%1.08B | 12.70%4.16B | 18.06%1.16B | -11.62%867M | -26.46%3.69B | 686M | -42.59%1.05B | -56.01%980M | 6.05%981M | 78.27%5.02B |
Gross dividend payment | ||||||||||
Basic earnings per share | 34.07%49.31 | 15.80%181.29 | 19.85%49.76 | -11.61%36.78 | -24.00%156.55 | 29.06 | -40.77%44.36 | -54.14%41.52 | 12.25%41.61 | 86.17%206 |
Diluted earnings per share | 34.07%49.31 | 15.80%181.29 | 19.85%49.76 | -11.61%36.78 | -24.00%156.55 | 29.06 | -40.80%44.3372 | -54.14%41.52 | 12.25%41.61 | 86.17%206 |
Dividend per share | 0 | 0.00%100 | 0 | 0 | 100.00%100 | 100 | 0 | 0 | 0 | 0.00%50 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |